Study of liver functions and some biomarkers in leukemia patients

Background: Acute lymphocytic leukemia (ALL) is a severe form of leukemia marked by an excess of lymphoblasts or lymphocytes in the bone marrow and peripheral circulation. While hepatitis is a well-known consequence of acute lymphoblastic leukemia treatment, the link between aberrant liver biochemis...

Full description

Bibliographic Details
Main Authors: Nuha A Altalib, Sura Khairialdeen Mohialdeen, Saba K Chlimeran
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Biomedical and Biotechnology Research Journal
Subjects:
Online Access:http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2023;volume=7;issue=2;spage=298;epage=302;aulast=Altalib
_version_ 1797649475107291136
author Nuha A Altalib
Sura Khairialdeen Mohialdeen
Saba K Chlimeran
author_facet Nuha A Altalib
Sura Khairialdeen Mohialdeen
Saba K Chlimeran
author_sort Nuha A Altalib
collection DOAJ
description Background: Acute lymphocytic leukemia (ALL) is a severe form of leukemia marked by an excess of lymphoblasts or lymphocytes in the bone marrow and peripheral circulation. While hepatitis is a well-known consequence of acute lymphoblastic leukemia treatment, the link between aberrant liver biochemistry and early leukemia presentation is poorly understood. The aim of this study is to assess the state of liver function in those with acute leukemia by monitoring the activities of alkaline phosphatase (ALP), aspartate aminotransferase (AST) , and alanine aminotransferase (ALT) , levels of bilirubin, as well as assessing the impact of ALL on other variables including calcium and phosphorus. Methods: In this research, 40 ALL patients and a control group of 40 healthy individuals were included in the study. The functioning of the liver was examined by measuring the activities of ALT, AST, ALP, and bilirubin levels in blood samples. Besides that, measuring serum calcium and phosphorus levels. Results: In accordance with the findings, there were substantial differences in ALT, AST, ALP, and bilirubin between the control and patient groups. In addition, there were a significant differences between patients and controls regarding the serum content of calcium and phosphorus. Conclusions: A liver function test should be done on leukemia patients before treatment, according to this study, which found that blood ALT, AST, ALP, and bilirubin levels are high at the time of acute leukemia diagnosis.
first_indexed 2024-03-11T15:47:37Z
format Article
id doaj.art-ffbbf71825894098a3b166b8ea392680
institution Directory Open Access Journal
issn 2588-9834
2588-9842
language English
last_indexed 2024-03-11T15:47:37Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Biomedical and Biotechnology Research Journal
spelling doaj.art-ffbbf71825894098a3b166b8ea3926802023-10-26T06:05:24ZengWolters Kluwer Medknow PublicationsBiomedical and Biotechnology Research Journal2588-98342588-98422023-01-017229830210.4103/bbrj.bbrj_79_23Study of liver functions and some biomarkers in leukemia patientsNuha A AltalibSura Khairialdeen MohialdeenSaba K ChlimeranBackground: Acute lymphocytic leukemia (ALL) is a severe form of leukemia marked by an excess of lymphoblasts or lymphocytes in the bone marrow and peripheral circulation. While hepatitis is a well-known consequence of acute lymphoblastic leukemia treatment, the link between aberrant liver biochemistry and early leukemia presentation is poorly understood. The aim of this study is to assess the state of liver function in those with acute leukemia by monitoring the activities of alkaline phosphatase (ALP), aspartate aminotransferase (AST) , and alanine aminotransferase (ALT) , levels of bilirubin, as well as assessing the impact of ALL on other variables including calcium and phosphorus. Methods: In this research, 40 ALL patients and a control group of 40 healthy individuals were included in the study. The functioning of the liver was examined by measuring the activities of ALT, AST, ALP, and bilirubin levels in blood samples. Besides that, measuring serum calcium and phosphorus levels. Results: In accordance with the findings, there were substantial differences in ALT, AST, ALP, and bilirubin between the control and patient groups. In addition, there were a significant differences between patients and controls regarding the serum content of calcium and phosphorus. Conclusions: A liver function test should be done on leukemia patients before treatment, according to this study, which found that blood ALT, AST, ALP, and bilirubin levels are high at the time of acute leukemia diagnosis.http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2023;volume=7;issue=2;spage=298;epage=302;aulast=Altalibacute leukemiabilirubinliver enzymes
spellingShingle Nuha A Altalib
Sura Khairialdeen Mohialdeen
Saba K Chlimeran
Study of liver functions and some biomarkers in leukemia patients
Biomedical and Biotechnology Research Journal
acute leukemia
bilirubin
liver enzymes
title Study of liver functions and some biomarkers in leukemia patients
title_full Study of liver functions and some biomarkers in leukemia patients
title_fullStr Study of liver functions and some biomarkers in leukemia patients
title_full_unstemmed Study of liver functions and some biomarkers in leukemia patients
title_short Study of liver functions and some biomarkers in leukemia patients
title_sort study of liver functions and some biomarkers in leukemia patients
topic acute leukemia
bilirubin
liver enzymes
url http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2023;volume=7;issue=2;spage=298;epage=302;aulast=Altalib
work_keys_str_mv AT nuhaaaltalib studyofliverfunctionsandsomebiomarkersinleukemiapatients
AT surakhairialdeenmohialdeen studyofliverfunctionsandsomebiomarkersinleukemiapatients
AT sabakchlimeran studyofliverfunctionsandsomebiomarkersinleukemiapatients